Related Experiment Videos
Paraneoplastic cerebellar disorders
1Department of Neurology, University of California, Los Angeles School of Medicine.
Abstract:
Paraneoplastic cerebellar degeneration typically begins with rapidly progressive ataxia of the trunk and extremities. Antineuronal antibodies are found in about half the patients. The most specific autoantibody is an anti-Purkinje cell antibody found in women with gynecologic tumors. Even after the tumor is removed, the cerebellar deficit persists in most patients.
Insights
Paraneoplastic cerebellar degeneration causes rapid ataxia. Anti-Purkinje cell antibodies, found in women with gynecologic tumors, are specific indicators, though deficits often persist post-treatment.
Area of Science:
- Neurology
- Oncology
- Immunology
Background:
- Paraneoplastic cerebellar degeneration (PCD) is a rare neurological disorder.
- It is characterized by rapidly progressive ataxia affecting the trunk and limbs.
- Antineuronal antibodies are detected in approximately 50% of PCD patients.
Purpose of the Study:
- To highlight the clinical presentation of PCD.
- To identify specific autoantibodies associated with PCD.
- To understand the long-term prognosis of cerebellar deficits in PCD.
Main Methods:
- Clinical case review.
- Serological testing for autoantibodies.
- Correlation of antibody findings with tumor type and patient outcomes.
Main Results:
- Rapidly progressive ataxia is the typical onset symptom.
- Anti-Purkinje cell antibodies are highly specific for PCD, particularly in women with gynecologic malignancies.
- Cerebellar dysfunction frequently persists even after successful tumor removal.
Conclusions:
- PCD is a distinct neurological syndrome linked to underlying malignancies.
- Specific autoantibodies, like anti-Purkinje cell antibodies, aid in diagnosis.
- The persistent nature of cerebellar deficits underscores the complexity of PCD management.